84 related articles for article (PubMed ID: 16782969)
1. Stillbirth and slow metabolizers of caffeine: comparison by genotypes.
Bech BH; Autrup H; Nohr EA; Henriksen TB; Olsen J
Int J Epidemiol; 2006 Aug; 35(4):948-53. PubMed ID: 16782969
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
[TBL] [Abstract][Full Text] [Related]
3. Association between caffeine intake and risk of Parkinson's disease among fast and slow metabolizers.
Tan EK; Chua E; Fook-Chong SM; Teo YY; Yuen Y; Tan L; Zhao Y
Pharmacogenet Genomics; 2007 Nov; 17(11):1001-5. PubMed ID: 18075470
[TBL] [Abstract][Full Text] [Related]
4. The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers.
Kotsopoulos J; Ghadirian P; El-Sohemy A; Lynch HT; Snyder C; Daly M; Domchek S; Randall S; Karlan B; Zhang P; Zhang S; Sun P; Narod SA
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):912-6. PubMed ID: 17507615
[TBL] [Abstract][Full Text] [Related]
5. Association of caffeine intake and CYP1A2 genotype with ovarian cancer.
Goodman MT; Tung KH; McDuffie K; Wilkens LR; Donlon TA
Nutr Cancer; 2003; 46(1):23-9. PubMed ID: 12925300
[TBL] [Abstract][Full Text] [Related]
6. Caffeine intake, CYP1A2 polymorphism and the risk of recurrent pregnancy loss.
Sata F; Yamada H; Suzuki K; Saijo Y; Kato EH; Morikawa M; Minakami H; Kishi R
Mol Hum Reprod; 2005 May; 11(5):357-60. PubMed ID: 15849225
[TBL] [Abstract][Full Text] [Related]
7. Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population.
Imaizumi T; Higaki Y; Hara M; Sakamoto T; Horita M; Mizuta T; Eguchi Y; Yasutake T; Ozaki I; Yamamoto K; Onohara S; Kawazoe S; Shigematsu H; Koizumi S; Kudo S; Tanaka K
Carcinogenesis; 2009 Oct; 30(10):1729-34. PubMed ID: 19643819
[TBL] [Abstract][Full Text] [Related]
8. Caffeine, selected metabolic gene variants, and risk for neural tube defects.
Schmidt RJ; Romitti PA; Burns TL; Murray JC; Browne ML; Druschel CM; Olney RS;
Birth Defects Res A Clin Mol Teratol; 2010 Jul; 88(7):560-9. PubMed ID: 20641098
[TBL] [Abstract][Full Text] [Related]
9. Low CYP1A2 activity associated with testicular cancer.
Vistisen K; Loft S; Olsen JH; Vallentin S; Ottesen S; Hirsch FR; Poulsen HE
Carcinogenesis; 2004 Jun; 25(6):923-9. PubMed ID: 14976127
[TBL] [Abstract][Full Text] [Related]
10. The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activities in humans.
Tsutsumi K; Kotegawa T; Matsuki S; Tanaka Y; Ishii Y; Kodama Y; Kuranari M; Miyakawa I; Nakano S
Clin Pharmacol Ther; 2001 Aug; 70(2):121-5. PubMed ID: 11503005
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'.
Keavney B; Danesh J; Parish S; Palmer A; Clark S; Youngman L; Delépine M; Lathrop M; Peto R; Collins R
Int J Epidemiol; 2006 Aug; 35(4):935-43. PubMed ID: 16870675
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of glutathione S-transferase A1 and O1 and breast cancer among postmenopausal Danish women.
Olsen A; Autrup H; Sørensen M; Overvad K; Tjønneland A
Eur J Cancer Prev; 2008 Jun; 17(3):225-9. PubMed ID: 18414193
[TBL] [Abstract][Full Text] [Related]
13. The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study.
Probst-Hensch NM; Sun CL; Van Den Berg D; Ceschi M; Koh WP; Yu MC
Carcinogenesis; 2006 Dec; 27(12):2475-82. PubMed ID: 16829689
[TBL] [Abstract][Full Text] [Related]
14. Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan.
Koda M; Iwasaki M; Yamano Y; Lu X; Katoh T
Environ Health Prev Med; 2017 Oct; 22(1):72. PubMed ID: 29165164
[TBL] [Abstract][Full Text] [Related]
15. Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.
William BM; Abdel-tawab AM; Hassan EA; Mohamed OF
Pol J Pharmacol; 2004; 56(4):445-9. PubMed ID: 15520499
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism in cytochrome P450 2E1 and interaction with other genetic risk factors and susceptibility to alcoholic liver cirrhosis.
Khan AJ; Ruwali M; Choudhuri G; Mathur N; Husain Q; Parmar D
Mutat Res; 2009 May; 664(1-2):55-63. PubMed ID: 19428381
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P4501A2 (CYP1A2) activity and lung cancer risk: a preliminary study among Chinese women in Singapore.
Seow A; Zhao B; Lee EJ; Poh WT; Teh M; Eng P; Wang YT; Tan WC; Lee HP
Carcinogenesis; 2001 Apr; 22(4):673-7. PubMed ID: 11285205
[TBL] [Abstract][Full Text] [Related]
18. Glutathione S-transferase polymorphisms and risk of differentiated thyroid carcinomas: a case-control analysis.
Ho T; Zhao C; Zheng R; Liu Z; Wei Q; Sturgis EM
Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):756-61. PubMed ID: 16847185
[TBL] [Abstract][Full Text] [Related]
19. The association between polymorphic genotypes of glutathione S-transferases and COPD in the Turkish population.
Calikoglu M; Tamer L; Ates Aras N; Karakaş S; Ercan B
Biochem Genet; 2006 Oct; 44(7-8):307-19. PubMed ID: 16977512
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of microsomal epoxide hydroxylase and glutathione S-transferases M1, T1 and P1, interactions with smoking, and risk for esophageal (Barrett) adenocarcinoma.
Casson AG; Zheng Z; Porter GA; Guernsey DL
Cancer Detect Prev; 2006; 30(5):423-31. PubMed ID: 17064856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
